EUVIMEDEUVIMED entdecken
Crossref

Patterns of Intravitreal Injection Utilisation, Treatment Burden, and Cost Implications in a Public Ophthalmology Service: A Retrospective Audit.

Adebusola Adenike Owokole, Thomas Ahern, Conall Hurley

The Operating Room Global Journal · 2025

DOI: 10.64573/torgj2512002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Operating Room Global Journal, 2025. Verfasst von Adebusola Adenike Owokole und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The global rise of intravitreal treatment has impacted ophthalmic service delivery, workforce demands, and healthcare cost. Public ophthalmology services must strike a balance between increasing clinical demand and sustainable resource usage. The aim of this study was to assess intravitreal injection patterns, temporal trends, as well as associated drug procurement costs in a public ophthalmology service.

Methods

A retrospective clinical audit was undertaken to analyze all intravitreal injections administered between June 2023 & September 2025. The data were taken from intravitreal therapy registers & comprised injection volume, agent selection, laterality, & monthly utilization trends. Drug procurement costs were determined using institutional pharmacy records. The data were anonymized & analyzed descriptively. Formal ethical approval was not necessary because this was a service evaluation audit.

Results

A total of 1,446 intravitreal injections were delivered during the audit period. Anti-VEGF therapy accounted for most of the activity, with aflibercept formulations representing 55.2% of all injections. Introduction of high dose aflibercept (8 mg) was associated with rapid adoption and displacement of alternative agents. The total drug acquisition cost was €697,504.90, with aflibercept contributing the greatest proportion of expenditure. Lower-cost agents accounted for a smaller proportion of injections.

Conclusion

Intravitreal therapy represents a substantial and growing clinical and economic burden within public ophthalmology services. Clinical effectiveness and treatment durability appear to be more important than cost when determining prescribing trends. Continuous auditing and service-level evaluation are required to guide sustainable service delivery, workforce planning, and policy development. Keywords: Intravitreal injections, Anti-VEGF therapy, Ophthalmology services, Health economics, Clinical audit.

Zitieren

APA

Owokole, A. A., Ahern, T., & Hurley, C. (2025). Patterns of Intravitreal Injection Utilisation, Treatment Burden, and Cost Implications in a Public Ophthalmology Service: A Retrospective Audit. The Operating Room Global Journal. https://doi.org/10.64573/torgj2512002

Vancouver

Owokole AA, Ahern T, Hurley C. Patterns of Intravitreal Injection Utilisation, Treatment Burden, and Cost Implications in a Public Ophthalmology Service: A Retrospective Audit. The Operating Room Global Journal. 2025. doi:10.64573/torgj2512002

BibTeX
@article{Owokole2025,
  author = {Owokole, Adebusola Adenike and Ahern, Thomas and Hurley, Conall},
  title = {Patterns of Intravitreal Injection Utilisation, Treatment Burden, and Cost Implications in a Public Ophthalmology Service: A Retrospective Audit},
  journal = {The Operating Room Global Journal},
  year = {2025},
  doi = {10.64573/torgj2512002}
}
Kostenlos starten →